Paul Pfeffer
- Physiology top 5%
- Asthma and respiratory diseases 40
-
- Vitamin D Research Studies 10
- Speech and Hearing top 5%
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 11
- Respiratory and Cough-Related Research 9
- Inhalation and Respiratory Drug Delivery 8
-
- Eosinophilic Esophagitis 13
-
- IL-33, ST2, and ILC Pathways 9
-
- Long-Term Effects of COVID-19 9
- Co-authors
- Catherine M. HawrylowiczDrew A. GlencrossNuria CamiñaElizabeth H. MannIan MudwayEmma S. ChambersChristopher J. CorriganFrank J. Kelly
- Journals
- Thorax (5 papers)The Journal of Allergy and Clinical Immunology In Practice (5 papers)BMJ Open (4 papers)
- Partner nations
- United KingdomUnited StatesSingapore
In The Last Decade
Paul Pfeffer
64 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Health, Toxicology and Mutagenesis 559
- Physiology 622
- Pathology and Forensic Medicine 331
- Speech and Hearing 123
- Pulmonary and Respiratory Medicine 546
Countries citing papers authored by Paul Pfeffer
This map shows the geographic impact of Paul Pfeffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Pfeffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Pfeffer more than expected).
Fields of papers citing papers by Paul Pfeffer
This network shows the impact of papers produced by Paul Pfeffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Pfeffer. The network helps show where Paul Pfeffer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul Pfeffer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotypebreakdown → | 2024 | 47 |
| 5 | 2024 | 10 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 0 | |
| 9 | Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational studybreakdown → | 2023 | 69 |
| 10 | 2023 | 1 | |
| 11 | 2023 | 2 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 13 | |
| 14 | 2022 | 35 | |
| 15 | 2021 | 47 | |
| 16 | 2020 | 52 | |
| 17 | 2018 | 31 | |
| 18 | 2017 | 28 | |
| 19 | 2017 | 12 | |
| 20 | 2015 | 56 |
About Paul Pfeffer
Paul Pfeffer is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine, Immunology and Neurology, having authored 80 papers that have together received 2.1k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (40 papers), Eosinophilic Esophagitis (13 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Vitamin D Research Studies (10 papers), Respiratory and Cough-Related Research (9 papers), IL-33, ST2, and ILC Pathways (9 papers), Long-Term Effects of COVID-19 (9 papers) and Inhalation and Respiratory Drug Delivery (8 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (559 citations), Physiology (622 citations), Pathology and Forensic Medicine (331 citations), Speech and Hearing (123 citations) and Pulmonary and Respiratory Medicine (546 citations). Paul Pfeffer has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include Catherine M. Hawrylowicz, Drew A. Glencross, Nuria Camiña, Elizabeth H. Mann, Ian Mudway, Emma S. Chambers, Christopher J. Corrigan, Frank J. Kelly, Jeremy M. Pfeffer and M.E. Hodson. Their work appears in journals such as Thorax, The Journal of Allergy and Clinical Immunology In Practice, BMJ Open, Journal of Allergy and Clinical Immunology and Clinical & Experimental Allergy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.